Drawing for LIFEMETRICS

USPTO serial 99086121

LIFEMETRICS

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SHINN, LAUREN DONGMI
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with LIFEMETRICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $849*

Plus Government fees of $1,050

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher D Olszyk, Jr.

Christopher D Olszyk, Jr. Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplementsACTIVE—
009Downloadable software in the nature of a mobile application for evaluating and reporting results of genetic and biomarker testing; Downloadable software in the nature of a mobile application for collection, recording, analysis, evaluation, reporting and processing of genetic test kit results; Downloadable software in the nature of a mobile application for the design, development and deployment of genetic testing kits and recovery and collection of results generated therefrom; Downloadable software in the nature of a mobile application for commercial analysis, data aggregation, information reportingACTIVE—
010Blood testing apparatusACTIVE—
035Computerized on-line ordering services in the field of genetic and biomarker testing kits; Outsource service provider in the field of business management of the selection, purchase, and ordering of genetic and biomarker testing kits; Order fulfillment services; Electronic processing of orders for others; Business consulting services in the field of selection, purchase and ordering of genetic testing kits; On-line retail store services featuring dietary and nutritional supplement productsACTIVE—
040Custom manufacture of dietary and nutritional supplements by pharmaceutical compoundersACTIVE—
042Scientific consulting and research services relating to foods and dietary supplements; Software as a service (SAAS) services featuring software for evaluating and reporting results of genetic and biomarker testing; Software as a service (SAAS) services featuring software for the design, development and deployment of genetic testing kits and recovery and collection of results generated therefrom; Software as a service (SAAS) services featuring software for commercial analysis, data aggregation, information reporting; Software as a service (SAAS) services featuring software for hosting software for use by others for use in data aggregation and information reporting; Platform as a service (PAAS) featuring computer software platforms for the collection, recording, analysis, evaluation, reporting and processing of genetic test kit results; Providing temporary use of a web-based software application for data aggregation, and information reporting; Technological planning and consulting services in the field of design, development, and deployment of genetic testing kits for scientific research purposes; Research in the field of bioinformatics; Blood testing for scientific research purposes; Genetic testing for scientific research purposes; Genetic mapping for scientific purposesACTIVE—
044Pharmaceutical compounding services; Medical testing services of blood serums; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Genetic counseling; Genetic testing for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2026EX1GSOU EXTENSION 1 GRANTED—
Jun 9, 2026EXT1SOU EXTENSION 1 FILED—
Jun 9, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 9, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 14, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 14, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 14, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 14, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 14, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 15, 2025DOCKASSIGNED TO EXAMINER—
Jul 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance